Macquarie Group
AMPH icon

Macquarie Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Macquarie Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,707
Closed -$839K – 2307
2022
Q2 		$895K Hold
25,707
– – ﹤0.01% 1509
2022
Q1 		$923 Buy
25,707
+19,559
+318% +$555K ﹤0.01% 1561
2021
Q4 		$144K Buy
6,148
+5,694
+1,254% +$116K ﹤0.01% 1839
2021
Q3 		$9K Hold
454
– – ﹤0.01% 2545
2021
Q2 		$9K Hold
454
– – ﹤0.01% 2476
2021
Q1 		$8K Sell
454
-215
-32% -$4K ﹤0.01% 2409
2020
Q4 		$13K Hold
669
– – ﹤0.01% 2275
2020
Q3 		$13K Hold
669
– – ﹤0.01% 2237
2020
Q2 		$15K Buy
+669
New +$12.3K ﹤0.01% 2224

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return